EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieKlinische Studie (Phase III)Open Access

Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

Florian Eichler, Christine N Duncan, Patricia L Musolino, Troy C Lund, Ashish O Gupta, Satiro De Oliveira, Adrian J Thrasher, Patrick Aubourg, Jörn-Sven Kühl, Daniel J Loes, Hernan Amartino, Nicholas Smith und 14 weitere

New England Journal of Medicine · 10.10.2024 · 391 (14) · 1302-1312

DOI: 10.1056/nejmoa2400442 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von Florian Eichler und 25 weiteren Autor:innen. Beteiligte Einrichtung: From Massachusetts General Hospital and Harvard Medical School (F.E., P.L.M.) and Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Ha…. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, ATP Binding Cassette Transporter, Subfamily D, Member 1, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Bluebird Bio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenoleukodystrophyATP Binding Cassette Transporter, Subfamily D, Member 1Genetic TherapyGenetic VectorsLentivirusAdolescentChildChild, PreschoolHumansMaleBrainHematopoietic Stem Cell TransplantationMagnetic Resonance ImagingFollow-Up StudiesTreatment OutcomeMyelodysplastic Syndromes

Substanzen

ABCD1 protein, humanATP Binding Cassette Transporter, Subfamily D, Member 1

Autor:innen und Institutionen

  • From Massachusetts General Hospital and Harvard Medical School (F.E., P.L.M.) and Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), Boston, Bluebird Bio, Somervill…

ORCID-Profile: David A Williams

Förderung

  • NINDS NIH HHS
  • Bluebird Bio

Zitieren

APA

Eichler, F., Duncan, C. N., Musolino, P. L., Lund, T. C., Gupta, A. O., De Oliveira, S., Thrasher, A. J., Aubourg, P., Kühl, J. S., Loes, D. J., Amartino, H., Smith, N., Folloni Fernandes, J., Sevin, C., Sankar, R., Hussain, S. A., Gissen, P., Dalle, J. H., Platzbecker, U., …, & Williams, D. A. (2024). Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine, 391(14), 1302-1312. https://doi.org/10.1056/nejmoa2400442

Vancouver

Eichler F, Duncan CN, Musolino PL, Lund TC, Gupta AO, De Oliveira S, et al. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine. 2024;391(14):1302-1312. doi:10.1056/nejmoa2400442

BibTeX
@article{Eichler2024,
  author = {Eichler, Florian and Duncan, Christine N and Musolino, Patricia L and Lund, Troy C and Gupta, Ashish O and De Oliveira, Satiro and Thrasher, Adrian J and Aubourg, Patrick and Kühl, Jörn-Sven and Loes, Daniel J and Amartino, Hernan and Smith, Nicholas and Folloni Fernandes, Juliana and Sevin, Caroline and Sankar, Raman and Hussain, Shaun A and Gissen, Paul and Dalle, Jean-Hugues and Platzbecker, Uwe and Downey, Gerald F and McNeil, Elizabeth and Demopoulos, Laura and Dietz, Andrew C and Thakar, Himal L and Orchard, Paul J and Williams, David A},
  title = {Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {14},
  pages = {1302--1312},
  doi = {10.1056/nejmoa2400442}
}
Kostenlos starten →